Unknown

Dataset Information

0

RIG-E, a human homolog of the murine Ly-6 family, is induced by retinoic acid during the differentiation of acute promyelocytic leukemia cell.


ABSTRACT: In vivo all-trans-retinoic acid (ATRA), a differentiation inducer, is capable of causing clinical remission in about 90% of patients with acute promyelocytic leukemia (APL). The molecular basis for the differentiation of APL cells after treatment with ATRA remains obscure and may involve genes other than the known retinoid nuclear transcription factors. We report here the ATRA-induced gene expression in a cell line (NB4) derived from a patient with APL. By differential display-PCR, we isolated and characterized a novel gene (RIG-E) whose expression is up-regulated by ATRA. The gene is 4.0 kb long, consisting of four exons and three introns, and is localized on human chromosome region 8q24. The deduced amino acid sequence predicts a cell surface protein containing 20 amino acids at the N-terminal end corresponding to a signal peptide and an extracellular sequence containing 111 amino acids. The RIG-E coded protein shares some homology with CD59 and with a number of growth factor receptors. It shares high sequence homology with the murine LY-6 multigene family, whose members are small cysteine-rich proteins differentially expressed in several hematopoietic cell lines and appear to function in signal transduction. It seems that so far RIG-E is the closest human homolog of the LY-6 family. Expression of RIG-E is not restricted to myeloid differentiation, because it is also present in thymocytes and in a number of other tissues at different levels.

SUBMITTER: Mao M 

PROVIDER: S-EPMC39161 | biostudies-other | 1996 Jun

REPOSITORIES: biostudies-other

altmetric image

Publications

RIG-E, a human homolog of the murine Ly-6 family, is induced by retinoic acid during the differentiation of acute promyelocytic leukemia cell.

Mao M M   Yu M M   Tong J H JH   Ye J J   Zhu J J   Huang Q H QH   Fu G G   Yu L L   Zhao S Y SY   Waxman S S   Lanotte M M   Wang Z Y ZY   Tan J Z JZ   Chan S J SJ   Chen Z Z  

Proceedings of the National Academy of Sciences of the United States of America 19960601 12


In vivo all-trans-retinoic acid (ATRA), a differentiation inducer, is capable of causing clinical remission in about 90% of patients with acute promyelocytic leukemia (APL). The molecular basis for the differentiation of APL cells after treatment with ATRA remains obscure and may involve genes other than the known retinoid nuclear transcription factors. We report here the ATRA-induced gene expression in a cell line (NB4) derived from a patient with APL. By differential display-PCR, we isolated a  ...[more]

Similar Datasets

| S-EPMC4001092 | biostudies-literature
| S-EPMC23834 | biostudies-literature
| S-EPMC1907337 | biostudies-literature
| S-EPMC5967331 | biostudies-literature
| S-EPMC6812572 | biostudies-literature
| S-EPMC7892950 | biostudies-literature
| S-EPMC4814328 | biostudies-literature
| S-EPMC8814755 | biostudies-literature
| S-EPMC8748438 | biostudies-literature
| S-EPMC5520717 | biostudies-literature